Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 5/20 | 0.43 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.43 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.41 |
| ▸ | DEPTOR | Q8TB45 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | CTSD | P07339 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 5/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL711911 | 0.98 | TDP1 (0.41) | TDP1TSHRCYP1A1CYP1B1NOX1 | |
| Formaldehyde SCHEMBL11097624 | 0.93 | TSHR (0.39) | TDP1TSHRCYP1A1CYP1B1NOX1 | |
| SCHEMBL20489080 | 0.76 | MAPT (0.38) | TSHRCYP1A1ALDH1A1HSD17B10ALOX15 | |
| SCHEMBL28454114 | 0.76 | ALDH1A1 (0.37) | TDP1ALDH1A1ALOX12MAPK1L3MBTL1 | |
| SCHEMBL9055960 | 0.69 | TDP1 (0.67) | TDP1TSHRCYP1A1CYP1B1NOX1 | |
| SCHEMBL20489078 | 0.69 | RAB9A (0.38) | TDP1ALDH1A1HSD17B10ALOX15ALOX12 | |
| SCHEMBL28562018 | 0.65 | LTA4H (0.35) | TSHR | |
| SCHEMBL28173379 | 0.65 | — | — | |
| SCHEMBL28357147 | 0.65 | IDO1 (0.43) | TDP1ALDH1A1ALOX12MEN1KMT2A | |
| SCHEMBL8162426 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210338896-A1 | METHOD FOR PRODUCING A MATERIAL FOR A BONE IMPLANT | STIMOS GMBH (DE) | 2021-11-04 | — | — | US | claimed |
| US-11112393-B2 | Chemical indicator and method of use | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-09-07 | — | — | US | claimed |
| US-20200179569-A1 | MATERIAL FOR A BONE IMPLANT AND METHOD FOR PRODUCING THE SAME | STIMOS GMBH (DE) | 2020-06-11 | — | — | US | claimed |
| EP-3544644-A1 | MATERIAL FOR A BONE IMPLANT AND METHOD FOR PRODUCING THE SAME | Stimos GmbH (DE) | 2019-10-02 | — | — | EP | claimed |
| US-20190154646-A1 | CHEMICAL INDICATOR AND METHOD OF USE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-05-23 | — | — | US | claimed |
| US-20140120069-A1 | Amphoteric Materials Based on Crosslinked Hyaluronic Acid, Method of Preparation Thereof, Materials Containing Entrapped Active Agents, Method of Preparation Thereof, and Use of Said Materials | CONTIPRO BIOTECH S.R.O. (CZ) | 2014-05-01 | — | — | US | claimed |
| EP-2702079-A1 | AMPHOTERIC MATERIALS BASED ON CROSSLINKED HYALURONIC ACID, METHOD OF PREPARATION THEREOF, MATERIALS CONTAINING ENTRAPPED ACTIVE AGENTS, METHOD OF PREPARATION THEREOF, AND USE OF SAID MATERIALS | Contipro Biotech s.r.o. (CZ) | 2014-03-05 | — | — | EP | claimed |
| WO-2012146218-A1 | AMPHOTERIC MATERIALS BASED ON CROSSLINKED HYALURONIC ACID, METHOD OF PREPARATION THEREOF, MATERIALS CONTAINING ENTRAPPED ACTIVE AGENTS, METHOD OF PREPARATION THEREOF, AND USE OF SAID MATERIALS | CONTIPRO BIOTECH S.R.O. (CZ) | 2012-11-01 | — | — | WO | claimed |
| WO-2002059093-A1 | METHODS AND COMPOSITIONS FOR BINDING NUCLEIC ACID MOLECULES | GENESPAN CORPORATION (US) | 2002-08-01 | — | — | WO | claimed |
| EP-0065483-A1 | Acyl aniline and acylnaphthyl amine microbicides, processes for preparing them and their use | CIBA-GEIGY AG (CH) | 1982-11-24 | — | — | EP | claimed |
| US-3945830-A | Dry pre-sensitized azide and silicone rubber containing planographic plates and methods of preparation | FUJI PHOTO FILM CO., LTD. (JA) | 1976-03-23 | — | — | US | claimed |
| JP-55042245-A | — | — | None | — | — | JP | disclosed |
| EP-4590428-A1 | SEPARATION MEDIA AND PURIFICATION METHODS FOR CARBOHYDRATE BINDING DOMAIN CONTAINING MOLECULES | Donaldson Company, Inc. (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-4590429-A1 | SEPARATION MEDIA AND PURIFICATION METHODS FOR CARBOHYDRATE CONTAINING MOLECULES USING THE SAME | Donaldson Company, Inc. (US) | 2025-07-30 | — | — | EP | disclosed |
| US-20250128187-A1 | SEPARATION MEDIA AND PURIFICATION METHODS FOR PURIFICATION TAG CONTAINING MOLECULES | DONALDSON COMPANY, INC. | 2025-04-24 | — | — | US | disclosed |
| US-5830434-A | Methods of treating non-insulin dependent diabetes mellitus with pancreatic polypeptide | MEDICAL UNIVERSITY OF SOUTH CAROLINA FOUNDATION FOR RESEARCH DEVELOPMENT (US) | 1998-11-03 | — | — | US | disclosed |
| US-4292392-A | ETCHABLE, DEVELOPABLE AND PERMEABLE USING AN ALKALINE AQUEOUS SOLUTION; CONTRAST | FUJI PHOTO FILM CO., LTD. (JP) | 1981-09-29 | — | — | US | disclosed |
| US-4266947-A | TO IMPROVE OXIDATION STABILITY AND ANTIKNOCK CHARACTERISTICS | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1981-05-12 | — | — | US | disclosed |
| JP-S5542245-A | PRODUCTION OF OPTICAL FIBER | NIPPON TELEGR & TELEPH CORP <NTT> | 1980-03-25 | — | — | JP | disclosed |
| US-3945830-A | Dry pre-sensitized azide and silicone rubber containing planographic plates and methods of preparation | FUJI PHOTO FILM CO., LTD. (JA) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140120069-A1 | Amphoteric Materials Based on Crosslinked Hyaluronic Acid, Method of Preparation Thereof, Materials Containing Entrapped Active Agents, Method of Preparation Thereof, and Use of Said Materials | CD44, HDGF, FGF2 | TDP1 2694/4885TSHR 4151/4885CYP1A1 3476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.